SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-209383
Filing Date
2017-06-21
Accepted
2017-06-21 16:07:02
Documents
5
Effectiveness Date
2017-06-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A d264267ddefa14a.htm DEFA14A 22055
2 GRAPHIC g264267ltr01a.jpg GRAPHIC 39108
3 GRAPHIC g264267ltr01b.jpg GRAPHIC 13697
4 GRAPHIC g264267ltr02a.jpg GRAPHIC 21952
5 GRAPHIC g264267ltr02b.jpg GRAPHIC 20303
  Complete submission text file 0001193125-17-209383.txt   153580
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-10352 | Film No.: 17922986
SIC: 2834 Pharmaceutical Preparations